| Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin) Y Lu, X Zi, Y Zhao, D Mascarenhas, M Pollak Journal of the National Cancer Institute 93 (24), 1852-1857, 2001 | 1082 | 2001 |
| Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: Implications for prostate … X Zi, R Agarwal Proceedings of the National Academy of Sciences 96 (13), 7490-7495, 1999 | 338 | 1999 |
| Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: induction of G1 arrest through an increase in Cip1/p21 concomitant with … X Zi, DK Feyes, R Agarwal Clinical cancer research: an official journal of the American Association …, 1998 | 280 | 1998 |
| Molecular mechanisms underlying IGF‐I‐induced attenuation of the growth‐inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells Y Lu, X Zi, M Pollak International journal of cancer 108 (3), 334-341, 2004 | 272 | 2004 |
| A Flavonoid Antioxidant, Silymarin, Inhibits Activation of erbB1 Signaling and Induces Cyclin-dependent Kinase Inhibitors, G1 Arrest, and Anticarcinogenic Effects … X Zi, AW Grasso, HJ Kung, R Agarwal Cancer research 58 (9), 1920-1929, 1998 | 271 | 1998 |
| Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic … X Zi, AR Simoneau Cancer research 65 (8), 3479-3486, 2005 | 246 | 2005 |
| Triazole–dithiocarbamate based selective lysine specific demethylase 1 (LSD1) inactivators inhibit gastric cancer cell growth, invasion, and migration YC Zheng, YC Duan, JL Ma, RM Xu, X Zi, WL Lv, MM Wang, XW Ye, ... Journal of medicinal chemistry 56 (21), 8543-8560, 2013 | 242 | 2013 |
| Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular … X Zi, Y Guo, AR Simoneau, C Hope, J Xie, RF Holcombe, BH Hoang Cancer Research 65 (21), 9762-9770, 2005 | 211 | 2005 |
| Silibinin up-regulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells X Zi, J Zhang, R Agarwal, M Pollak Cancer research 60 (20), 5617-5620, 2000 | 177 | 2000 |
| Novel cancer chemopreventive effects of a flavonoid antioxidant silymarin: Inhibition of mRNA expression of an endogenous tumor promoter TNFα X Zi, H Mukhtar, R Agarwal Biochemical and biophysical research communications 239 (1), 334-339, 1997 | 171 | 1997 |
| Wnt inhibitory factor 1 decreases tumorigenesis and metastasis in osteosarcoma EM Rubin, Y Guo, K Tu, J Xie, X Zi, BH Hoang Molecular cancer therapeutics 9 (3), 731-741, 2010 | 170 | 2010 |
| The Wnt inhibitory factor 1 restoration in prostate cancer cells was associated with reduced tumor growth, decreased capacity of cell migration and invasion and a reversal of … DS Yee, Y Tang, X Li, Z Liu, Y Guo, S Ghaffar, P McQueen, D Atreya, J Xie, ... Molecular cancer 9, 1-14, 2010 | 167 | 2010 |
| Rhodiola rosea extracts and salidroside decrease the growth of bladder cancer cell lines via inhibition of the mTOR pathway and induction of autophagy Z Liu, X Li, AR Simoneau, M Jafari, X Zi Molecular carcinogenesis 51 (3), 257-267, 2012 | 155 | 2012 |
| Molecular targeted approaches to cancer therapy and prevention using chalcones D D Jandial, C A Blair, S Zhang, L S Krill, YB Zhang, X Zi Current cancer drug targets 14 (2), 181-200, 2014 | 142 | 2014 |
| Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos‐2 cells Y Guo, X Zi, Z Koontz, A Kim, J Xie, R Gorlick, RF Holcombe, BH Hoang Journal of Orthopaedic Research 25 (7), 964-971, 2007 | 141 | 2007 |
| Rhodiola rosea L.: an Herb with Anti-Stress, Anti-Aging, and Immunostimulating Properties for Cancer Chemoprevention Y Li, V Pham, M Bui, L Song, C Wu, A Walia, E Uchio, F Smith-Liu, X Zi Current pharmacology reports 3, 384-395, 2017 | 132 | 2017 |
| WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells Y Tang, AR Simoneau, W Liao, G Yi, C Hope, F Liu, S Li, J Xie, ... Molecular cancer therapeutics 8 (2), 458-468, 2009 | 132 | 2009 |
| Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis B Liu, KW Lee, M Anzo, B Zhang, X Zi, Y Tao, L Shiry, M Pollak, S Lin, ... Oncogene 26 (12), 1811-1819, 2007 | 131 | 2007 |
| Lycopene enhances docetaxel's effect in castration-resistant prostate cancer associated with insulin-like growth factor I receptor levels Y Tang, B Parmakhtiar, AR Simoneau, J Xie, J Fruehauf, M Lilly, X Zi Neoplasia 13 (2), 108-119, 2011 | 123 | 2011 |
| Effects of the kava chalcone flavokawain A differ in bladder cancer cells with wild-type versus mutant p53 Y Tang, AR Simoneau, J Xie, B Shahandeh, X Zi Cancer prevention research 1 (6), 439-451, 2008 | 115 | 2008 |
